RankAlpha logo
Back to Rankings

ANAB

AnaptysBioC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Current thesis
The bull case is that the completed spin removes structural uncertainty, leaves ANAB with a simpler royalty-management story, and eventually allows investors to value Jemperli and imsidolimab economics plus aggressive capital returns more cleanly once initial post-spin disclosures arrive [#8-K-2026-04-20] [#PR-2026-03-27].
Posture
Mixed
Lead driver
Sentiment
What changed
Next scheduled catalyst: earnings 2026-09-11 · AMC.
What can break
Any underwhelming capital return execution could weaken the core standalone royalty-equity thesis.
Momentum
32
Value
50
Sentiment
59
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $56.00 · Bull $68.00 · Bear $38.00Analysis 2026-04-21; returns require an exact persisted reference.
Earnings
32 · Non-qualifying
Next 2026-09-11 · AMC
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-21 • Model: RankAlpha Sentiment Codex
Earnings Setup
As of 2026-09-10 • RankAlpha AI
Investment thesis
As of 2026-09-09

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions

Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $86.20
Why
Momentum32 · Δ7d +7.9
Value50 · Δ7d -0.0
Sentiment59 · Δ7d +3.0
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Earnings surprise screen
32Non-qualifying2026-09-11 amc
View setup

AnaptysBio had a visible royalty and regulatory catalyst with strong prior Jemperli sales, but consensus data conflicted materially across vendors, the stock weakened into the print, and no close-location or positive price-strength confirmation was present.

Screen as of 2026-09-10. Window 2026-09-10 to 2026-09-16.

Confirming evidence

  • Next scheduled catalyst: earnings 2026-09-11 · AMC.
  • Pre-earnings setup: 32 / non-qualifying.
  • Sentiment remains the lead driver in the composite, 7D delta +3.0.

Contradictions & invalidation

  • Any underwhelming capital return execution could weaken the core standalone royalty-equity thesis.
  • Limited direct peer set and low coverage reduce valuation support and can amplify volatility around small disclosure changes.
  • The bear case is that ANAB is now heavily dependent on a narrow set of partner-controlled royalty streams, with cash flow still partly obscured by the Sagard monetization structure; if partner sales cadence or paydown timing disappoints, the standalone royalty vehicle may not sustain the premium implied by legacy pre-spin expectations [#10-K-2026-03-03] [#PR-2025-09-29].

Catalyst clock

2026-09-11 · AMC

Early post-spin capital allocation disclosures

Lead driver: Sentiment · See AI snapshot
Momentum
32
9% active weight
Current posture
7d trendImproving
Δ7d
+7.9
Δ21d
-47.2
Value
50
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+8.6
Sentiment
59
62% active weight
Current posture
7d trendImproving
Δ7d
+3.0
Δ21d
+7.0
Why this grade

Composite grade C. Momentum 32.4 / Value 49.7 / Sentiment 58.9

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-04-21. Scenario method

B+
Bull case
25%
Probability
Target price
$68.00
Analysis reference price unavailable
Analysis 2026-04-21 · RankAlpha Sentiment Codex
Most likely
B
Base case
45%
Probability
Target price
$56.00
Analysis reference price unavailable
Analysis 2026-04-21 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$38.00
Analysis reference price unavailable
Analysis 2026-04-21 · RankAlpha Sentiment Codex
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$1.77B
Beta
0.36
Shares Out
29.61M
P/E (TTM) · Derived
-129.7
P/S (TTM)
7.06
P/FCF (TTM) · Derived
-502.44
Rev YoY
-8.0%
EPS YoY
+43.6%
Gross Margin
+99.0%
Op Margin
+17.6%
Net Debt
-$21M
Current Ratio
7.58
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data